Future treatments could be used to strengthen already healthy bones and, in cases of osteoporosis, rebuild degraded bone to full strength.
https://t.co/T3QKCjiZuA
@unileipzig@ShandongU
🌑 THE DAY THE SUN DISAPPEARS...
On August 2, 2027, day will briefly turn into night as the longest total solar eclipse visible from land in the 21st century crosses parts of Europe, North Africa, and the Middle East. For up to 6 minutes and 23 seconds, the Moon will completely block the Sun, revealing its glowing corona and creating an unforgettable twilight in the middle of the day.
A rare cosmic event that millions may witness—but another eclipse this long over accessible land won't happen again until the next century.
Source:
National Aeronautics and Space Administration. Total Solar Eclipse of August 2, 2027. NASA.
«Волшебное кольцо» (1979) — это просто машина цитат:
— Эта Ульянка хуже карасину!
— Ваня, я ваша навеки!
— Мужичок, пошто вы всё с животными балуете?
Классика, которую можно пересматривать вечно 😅
"These cells are probably trying to do something good: clearing up damage. But they become overloaded, so to speak. As a result, they can no longer effectively contribute to repair."
https://t.co/ka7W0Ft1AT
🚨 A HUG CAN CHANGE YOUR BODY IN MINUTES
A simple hug or cuddle may do far more than people realize. Scientists say physical touch can calm the brain, lower stress, ease anxiety, improve sleep, and even help support the immune system.
The most surprising part? Your body releases powerful “feel-good” chemicals during close human contact — almost like a natural healing response. In a world full of stress, comfort may be one of the most powerful medicines we already have.
Source: Field, T. Touch for socioemotional and physical well-being: A review. Cacioppo, S., & Cacioppo, J. T. Social relationships and health: The toxic effects of perceived social isolation.
Depletion of sex hormones that enable male development induces neuroinflammation that disrupts hormonal signalling and immune responses against brain tumours
https://t.co/nDwYngPtuY
The herpes simplex virus type 1 (HSV-1), the same virus responsible for cold sores in billions of people worldwide, is being genetically engineered into a potent new cancer therapy. Scientists are reprogramming this virus into oncolytic viruses designed to selectively infect, replicate within, and destroy tumor cells while sparing healthy tissue.
Once injected into a tumor, the modified virus multiplies rapidly until the cancer cell bursts. Beyond this direct cell-killing effect, the destruction of tumor cells releases tumor-specific antigens and danger signals that activate the patient’s immune system. This triggers a broader systemic immune response capable of attacking cancer cells not only at the injection site but also at distant, untreated tumors.
Early clinical results have been encouraging. In advanced melanoma patients who had already failed standard immunotherapies, combination treatment with the oncolytic HSV-1 RP1 (vusolimogene oderparepvec) and nivolumab produced meaningful responses in approximately one-third of participants, with some experiencing complete tumor disappearance. Side effects are generally mild to moderate, often limited to flu-like symptoms such as fever and fatigue.
Larger phase 3 trials are now underway to confirm these benefits across broader patient populations. While still in development, this approach represents a promising new frontier in cancer immunotherapy, transforming a lifelong virus into a precision tool that helps the immune system recognize and eliminate tumors.
[Andtbacka, R. H. I. et al. Efficacy and safety of vusolimogene oderparepvec plus nivolumab in patients with advanced melanoma that progressed on anti–PD-1 therapy: Results from the IGNYTE trial. Journal of Clinical Oncology (2025). DOI: 10.1200/JCO-25-01346]